Connect with us

Women’s Health

RTL Today – Women’s Health Action Day: Regular screening and vaccination can prevent cervical cancer

Published

on

On the Day of Action for Women’s Health, the National Health Laboratory (LNS) aims to raise awareness of the importance of prevention.

Some good news from the start: women who regularly see a gynecologist and have swab samples analyzed have virtually no risk of developing cervical cancer. As part of the day of action for women’s health, the LNS would like to shed light on the current state of research and the importance of prevention.

Every woman who has sexual intercourse is at risk of developing cervical cancer. The disease is caused by what is known as the human papillomavirus (HPV), which can be transmitted through sexual intercourse. There are over 200 types of HPV, 14 of which can cause cancer – the focus is on “can” because just being in your body does not automatically cause cancer, Dr. Marc Fischer, who carries out cell analyzes at the LNS.

Regular checkups are important, however, as it is estimated that 10 to 12% of the population have these high-risk types of HPV. On average, it takes 10 to 15 years between the initial infection and an invasive outbreak. For this reason, a gynecologist will regularly send a swab of cervical cells to the LNS. In the laboratory, the swab is then checked for abnormalities under a microscope. If abnormalities are discovered, a so-called human papillomavirus test, or HPV test for short, is carried out. This test can determine the exact type of virus.

In 2019, the LNS carried out around 130,000 of these screenings. Anomalies were discovered in 7% of all cases. However, this can sometimes be simple inflammation as well, explains Dr. Fisherman. But even if it is a type of HPV, there is no need to panic. In this case, the course of the disease is closely followed. In many cases, the virus will go away on its own after a period of time.

In 0.3% to 0.4% of all cases, however, it was a pre-cancerous stage. Dr. Fischer emphasizes that this still means nothing, however. This is because it is usually still possible to surgically remove the diseased tissue as long as it has not been invaded. Chemotherapy is only necessary in advanced stages. In Luxembourg, however, it is extremely rare for a cancer to be discovered at this stage.

Besides using a condom, the best protection against cervical cancer is with a vaccine, which has been available since 2000. This vaccine is most effective when given before the first sexual intercourse. It protects a person from seven types of HPV, including two of the most dangerous. It should be noted that young men can also receive the vaccine. Not only because they can potentially transmit the virus, but also because HPV can also cause certain types of cancer in them, Dr. Fisherman.

However, since this vaccine has only been administered on a large scale since 2008, it can be assumed that a large proportion of the adult population is not protected by this vaccination. Dr. Fischer still thinks it makes sense to receive the shock retrospectively, even for people who are already having sexual intercourse. The vaccine can provide additional protection for adults. A simple review can show how important this protection is. Before the screening program was launched in the 1960s, cervical cancer was the most common fatal cancer in women.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Women’s Health

Organon announces commitment to accelerating advancements in women’s health at EXPO 2020

Published

on

With a diverse portfolio that includes women’s health, biosimilars and established brands, Organon is the only company in the world that is solely focused on women’s health. Serving 140 markets with 60 drugs and solutions, the healthcare company now operates in the United Arab Emirates, Oman, Kuwait, Qatar, KSA, Egypt, Lebanon, Jordan, Turkey and Ukraine. In line with the UN Sustainable Development Goal for Gender Equality and the Empowerment of Women, Organon’s mission is to improve and innovate health care for women.

Comment on the start, Ramy Koussa, Vice President of Organon MENAT, said: “Our goal is to advance health care for women in MENAT by addressing their unmet needs and helping to build a healthier and better future for all women, families and communities With local authorities and industry stakeholders, we seek to shift the paradigm of women’s health beyond reproductive health and embrace the full life cycle. This forum is an important first for us at Organon MENAT to listen to women and become a trusted partner in the health care of women in the region, “he added.

Topics discussed by the respected women’s health experts included existing data gaps hindering improvements in women’s health, monitoring progress towards the UN Sustainable Development Goal of gender equality, investing in health care and accelerating change through economic growth Strengthening. Panelists present included: Dr Susanne Fiedler, Chief Commercial Officer of Organon; Susanne Michail, Regional Director of the United Nations Unit for Gender Equality and Women’s Empowerment in Arab States; Bathylle Missika, Head of Networks, Partnerships and Gender at the OECD Development Center; Myra Betron, Director of Gender Issues at Jhpeigo; and Dina El– Shenoufy, Chief Investment Officer at Flat6lab.

MS. Susanne Michail, Regional Director of the United Nations Unit for Gender Equality and Women’s Empowerment in Arab States, said: “A better understanding and better management of the unmet health needs of women is essential for achieving the sustainable goals of the 2030 Agenda, including the extremely important gender equality and economic empowerment goals for women. In addition to considering health services as a fundamental right per se, women’s health is also directly related to economic development. For example, women could add $ 28 trillion (or 26% of global GDP) of the world economy by 2025 when their health issues are addressed so they can better participate in the labor market. So it is exciting to see how Organon is focusing on the health needs of women and accelerating advances in women’s health in the region. “

Commentary after the panel discussion, Dr Susanne Fiedler, Organon’s Chief Commercial Officer, said, “At Organon we are working towards a world where every woman can enjoy better health. To this end, we will work closely with industry stakeholders, from private to public organizations, health care providers, Patient societies and others to develop efficient and differentiated operating models to improve the delivery of health services to women across the region. ”

DR Sawsan AS Al Madhi, Director General, Friends of Cancer Patients, added, “Friends of Cancer Patients (FOCP) is a patient-centric organization. We fundamentally believe that the patient must be heard and empowered to ensure the best possible care. We welcome the introduction of Organon across the board middle East, North africa and Turkey Region and look forward to our collaborative approach to better understand and address the unmet health needs of women. “

With a dynamic business model and entrepreneurial approach, and in line with its commitment to accelerating progress in women’s health, the company also launched the Femtech Accelerator Program in the middle East and North africa together with the early-stage venture capital firm Flat6Labs, the result of their first official regional collaboration. Together, the companies will support women-led and focused start-ups in the digital healthcare sector and help them develop a Medium Viable Product (MVP). Selected start-ups take part in a two-month intensive acceleration program with individual coaching and mentoring with relevant leading industry experts, online training and matchmaking with potential technology, investment and business partners.

Copyright © 2021 Organon Group of Companies. All rights reserved. If you need an update, have an inquiry or need to report a side effect, you can contact the following address:

Tel .: +9714 5639700
Fax: +9714 5805629
E-mail: [email protected]

About Organon:

Organon (NYSE: OGN) is a global healthcare company that emerged from a spin-off from Merck and known outside the United States as MSD The United States and Canadato focus on improving women’s health throughout their lives. For your health, the company has a portfolio of more than 60 drugs and products from a number of therapeutic areas. Led by the reproductive health portfolio coupled with an expanding biosimilars business and a stable franchise of established drugs, Organon’s products generate strong cash flows that will support investments in future growth opportunities in women’s health, including business development. In addition, Organon is pursuing opportunities to work with biopharmaceutical innovators who wish to commercialize their products by leveraging their size and presence in rapidly growing international markets.

Organon has a global presence of significant size and geographic reach, world class commercial capabilities, and approximately 9,000 employees headquartered in Jersey City, New Jersey.

For more information, visit www.organon.com and connect with us on LinkedIn, Instagram and Facebook.

Photo – https://mma.prnewswire.com/media/1671656/Organon.jpg
Logo – https://mma.prnewswire.com/media/1671657/Organon_Logo.jpg

SOURCE Organon

similar links

https://www.organon.com

Continue Reading

Women’s Health

FIGO 2021 World Congress Blog – Day Five

Published

on

Investigation of Controversies in Treatment at the Israel Forum

The fifth day of the FIGO 2021 World Congress began with a session on treatment controversies, which took place live on the Israel Forum and was streamed directly on our virtual platform. During that session there was a fascinating debate about the use of valaciclovir to prevent vertical transmission of cytomegalovirus. Dr. Yacov Amir spoke first, suggesting that valaciclovir was an effective form of treatment, followed by Dr. Rinat Gabbay-Benziv, who argued that it had its limits. The session ended with a panel discussion and questions and answers between the speakers and moderators.

COVID-19 and the women’s health crisis

We then had the honor of enjoying the BN Purandare lecture organized by the Federation of Obstetric and Gynecological Societies of India (FOGSI). Dr. Alpesh Gandhi gave a keynote on the “Women’s Health Crisis During the COVID-19 Pandemic”.

In his lecture, Dr. Gandhi provided a comprehensive look at the many impacts of the pandemic on women’s health, including an increase in maternal mortality, limited access to family planning and abortion services, delays in gynecological surgeries, and a lack of access to COVID vaccinations for pregnant women. He stressed that the pandemic had resulted in women avoiding health facilities and highlighted the essential role of community health workers, midwives and telemedicine in addressing this challenge.

Learn more about FIGO’s pen surgery training initiative

Following this, the FIGO Committee for Fistulas and Genital Trauma organized a meeting on the FIGO Fistula Surgery training initiative. Gillian Slinger, Senior Project Manager of the FIGO initiative, started the session with an update on the initiative’s recent successes and future plans to expand the training program. Dr. Fekade Aneyachew Aklilu described the role of trainers in delivering fistula surgery training in resource-poor environments and the challenges one faces in becoming a trainer.

Dr. Hillary Mabeya then gave a presentation of advice for aspiring fistula surgery trainees and gave an insight into what to expect when training to become a fistula surgeon. Dr. Andrew Browning closed the session with a talk on persistent incontinence after fistula repair – with an emphasis on diagnosis, management and corrective surgery.

The meeting was rounded off by a discussion between Ms. Slinger and Dr. Mabeya on the importance of continuous training, the essential role of working with larger teams beyond surgeons, and the role FIGO has played in eradicating fistulas around the world.

Prenatal diagnostics

Later, the FIGO Maternal and Fetal Health Track organized a session on prenatal diagnostics. We first heard from Professor Lyn Chitty who gave a talk on rapid fetal exome sequencing for the diagnosis of monogenic conditions in fetuses with structural abnormalities. She focused on explaining what rapid fetal exome sequencing is, what it will deliver, and provided an overview of how it is currently being used in the UK NHS. Professor Svetlana Rechitsky focused on pre-implantation genetic testing (PGT-A) with Embryo Selection, in particular on the management of mosaic embryos.

Dr. James Goldberg spoke about advanced pre-conceptual vehicle screening, focusing on the medical history, recent changes to key guidelines and guidelines, and the clinical utility of these tests. Dr. Antoni Borrell concluded the session with a presentation on maternal plasma aneuploidy testing for all chromosomes, focusing mainly on cell-free DNA (cfDNA) testing.

Global Perspectives on Self-Administered Abortion

We then had an exciting live panel on “Spreading the Revolution – Why Investing in Self-Administered Abortions is the Way Forward to Realizing Women’s Right to Physical Autonomy”, led by Dr. Dorothy Shaw. The panel started with an introduction by Dr. Bela Ganatra on developing the World Health Organization’s recommendations on medical abortion over the past 20 years.

An exciting conversation followed between Dr. Shaw, Dr. Ganatra, Dr. Laura Gil, Professor Dame Lesley Regan, Mr. Shabin Shrestha and Ms. Jedidah Maina. The discussion focused on the main obstacles to self-directed abortion, namely the over-regulation of medical abortion, criminalization, social stigma and a lack of understanding of the issue.

The speakers shared valuable insights from around the world, used their platform to demand an approach that prioritizes listening to women and trusts them to know how to make decisions about their reproductive life. Speakers highlighted the key role of evidence in lobbying, improving access to information and training, removing barriers to access to safe abortion services, and appreciating the voices of people who have had experiences seeking abortion care.

End the day in Europe

The day ended with the Europe Regional Evening, organized by the European Board and College of Obstetrics and Gynecology (EBCOG), which started with a dedicated panel on the effects of COVID on OBGYN education in the region. We then heard from several speakers about examples of European learning fields. The evening ended with a conversation about OBGYN care for migrants in Europe. Each session of the evening was pleasantly ended with musical interludes by the renowned opera singer Danae Kontora, whose incredible voice could be heard at various points on the night of study.

Recordings of the entire meeting will be available on demand on the virtual congress platform within 24 hours.

To learn more about the congress or to register, visit www.figo2021.org.

Continue Reading

Women’s Health

Program focused on women vets health care could become mandatory for transitioning troops

Published

on

Following a proposal proposed by Congress to ensure women get the information they need about post-military health support services, transition into health care training could become a requirement for women service members leaving their ranks.

“It should be a compulsory program where female veterans can come together and talk about some of their problems in a safe place so that the Department of Defense and their military departments understand what their problems might be,” said Rep. Julia Brownley. D-California, on Tuesday.

“I think one of the problems is that women don’t even know about the program or have access to the program. And certainly, if it is not compulsory, you might miss it completely. “

TIED TOGETHER

Your comments came at a House Veterans Affairs Committee hearing on available support services for female troops and veterans.

As part of the discussion, panel members praised the transition to women’s health training program jointly run by VA and Defense Department officials over the past three years to provide more targeted information on post-military health care and support services.

But despite good reviews of the program so far, the panel’s lawmakers said they felt more needs to be done to promote it to ensure that female veterans are aware of it and have access to training.

Only about 37 percent of all female veterans in America are enrolled in VA health programs, according to a Congressional Research Service report earlier this year. For comparison: around half of all male veterans are enrolled in the system.

Health care officials have said that in transitioning from military life, it is critical to ensure veterans know and understand their available benefits – especially medical care – how to access them, and offer solutions to challenges such as financial problems, mental health issues, and thoughts of suicide .

Only about 1,500 female service workers have completed the Women’s Health Transitioning Training in recent years, which is currently a self-directed online course offered through the Transition Assistance Program. Of this group, 54 percent chose to enroll in VA health care after completing the course.

Lawrencia Pierce, assistant director of VA’s Office for Outreach, Transition and Economic Development, said officials plan to expand the program in the coming months to include virtual instructors to allow for greater engagement and feedback from course participants.

But William Mansell, director of the Defense Support Service Center, said officials hadn’t thought of making the course compulsory for women who are leaving the military because they prefer to keep the transition classes as flexible as possible to allow the transition forces be able to choose the training that best suits them needs.

“There are alternative avenues and different levels of support that allow service members to control their transition processes,” he said. “And if a changing service member states that they need this training, or if their self-assessment indicates that they need it, then they will get it.”

TIED TOGETHER

The Women in Military Service to America Memorial, the only national museum honoring military women, celebrated its 15th anniversary on October 20, 2012.

However, Browley and other lawmakers said this approach may not be strong enough, especially given the preconceived notion that VA health care is more focused on helping men than women.

“When women leave, they need to know what the options are,” she said. “And many of them leave on a traumatic basis. So many women are subjected to harassment or assault that happened to them during their military service. “

There are currently no pending laws on the matter, but Brownley indicated that if the expansion of training progresses slowly, she could begin creating such a plan.

Along with the addition of virtual coaches, Defense and VA officials said they plan to increase funding for the program in the coming months to allow for wider program visibility through existing programs and transition networks.

Leo covers Congress, Veterans Affairs, and the White House for Military Times. He has been reporting on Washington, DC since 2004, focusing on military personnel and veteran politics. His work has received numerous awards, including a 2009 Polk Award, a 2010 National Headliner Award, the IAVA Leadership in Journalism Award, and the VFW News Media Award.

Continue Reading
Advertisement

Trending